Hidden Heart Valve Disease: How AI-Enhanced ECG Analysis Is Reshaping Early Detection in

Why Does Aortic Stenosis Go Undetected for So Long?

The aortic valve opens and closes roughly 100,000 times per day. In aortic stenosis, calcium deposits progressively stiffen the valve leaflets, narrowing the opening through which blood exits the heart. Because this process unfolds over years, the left ventricle adapts through concentric hypertrophy — thickening its walls to maintain output against rising resistance. Patients may remain asymptomatic for a prolonged period even as the valve area shrinks substantially below normal.

This compensatory phase creates a clinical paradox: by the time classic symptoms appear — exertional breathlessness, exercise intolerance, dizziness, or chest tightness — the disease is often severe. Population-based echocardiographic studies, including the landmark Tromsø Study published in the European Heart Journal, have shown that a significant proportion of older adults with moderate-to-severe aortic stenosis are unaware of their condition. Without intervention, symptomatic severe aortic stenosis carries a grim prognosis, with historical data suggesting mortality rates exceeding 25% per year once heart failure develops. This diagnostic gap has fueled interest in leveraging existing clinical data — particularly ECGs — as an opportunistic screening tool.

What ECG Patterns Does the AI Algorithm Recognize?

Human cardiologists have long recognized that severe aortic stenosis can produce ECG findings such as left ventricular hypertrophy patterns, left atrial enlargement, and ST-T wave changes. However, these individual features lack the sensitivity and specificity needed for reliable screening. Many patients with significant valve disease have ECGs that appear normal or show only nonspecific changes to the trained eye.

AI algorithms approach the problem differently. Rather than relying on predefined criteria, convolutional neural networks analyze the raw ECG waveform across all 12 leads simultaneously, identifying complex multivariate patterns that correlate with echocardiographic findings. Research published by Attia, Cohen-Shelly, and colleagues at Mayo Clinic has demonstrated that these patterns likely encode information about myocardial strain, diastolic filling pressure changes, and early fibrotic remodeling — physiological consequences of chronic pressure overload that leave electrical fingerprints too subtle for conventional interpretation. The model processes an ECG in under five seconds, generating a probability score that clinicians can use to prioritize patients for confirmatory echocardiography.

How Could Routine ECG Screening Change Patient Outcomes?

The clinical value of early detection lies in the growing evidence that intervening before irreversible myocardial damage occurs leads to better long-term survival. The RECOVERY trial and the EARLY TAVR trial have both explored the benefits of earlier valve replacement in asymptomatic or mildly symptomatic patients, with results suggesting improved outcomes compared to watchful waiting in selected populations.

From a health systems perspective, AI-ECG screening is attractive because it repurposes infrastructure that already exists. ECGs are among the most commonly performed cardiac tests globally, with tens of millions recorded each year across primary care offices, preoperative assessments, and emergency departments. Adding an automated algorithm requires only a software update — no new hardware, no additional patient visits, and minimal added cost. Modeling studies have suggested that systematic screening of adults over 65 during routine ECG encounters could identify a substantial number of previously unrecognized cases, enabling surveillance echocardiography and planned interventions rather than emergency presentations. As regulatory pathways for AI diagnostic tools mature and real-world deployment data accumulates, the integration of valve disease screening into standard ECG reporting appears increasingly feasible.